PROTEIN MARKER FOR DIAGNOSTIC OF PROSTATE CANCER, METHOD FOR MEASURING THE NUMBER OF MARKER AND ALGORITHM FOR INTERPRETING THE RESULT

摘要

The invention relates to the field of biology and medicine, namely to oncology, and can be used to diagnose prostate cancer (PCa). To do this, use a new marker of prostate cancer, detected in the patient’s whole urine, which is an integrin alpha V or its fragment. A method for diagnosing prostate cancer is also provided, including detecting integrin alpha V in a patient’s whole urine and a diagnostic kit comprising at least one antibody specific for integrin alpha V, or a functional fragment thereof. The invention allows for non-invasive diagnosis of prostate cancer using a simple, sensitive, reliable method, applicable in a standard clinical laboratory of clinical or outpatient medical institutions.